Ireland
--:--IST
Latest
Clinical Trials in Taiwan / NCT07805096
Recruiting Not applicable

Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health

NCT07805096 · tracked via the Priya Life Science Taiwan tracker
Sponsor
National Defense Medical University, Taiwan
Phase
Not applicable
Started
2025-12-30
Last updated
2026-09-04

Condition(s) studied

Leukemia (Both ALL and AML)Brain Tumors

Investigational drug(s) / intervention(s)

Parent Smart Holistic Health Care Platform (P-SHHCP)Child Smart Holistic Health Care Platform (C-SHHCP)

Parent Smart Holistic Health Care Platform (P-SHHCP): The Parent Smart Holistic Health Care Platform (P-SHHCP) is a digital supportive care intervention designed for parents who are the primary caregivers of children with cancer. The platform aims to strengthen communication and connection between parents and health care providers and to provide holistic support addressing physical, psychological, social, and spiritual needs during the child's cancer treatment.

Child Smart Holistic Health Care Platform (C-SHHCP): The Child Smart Holistic Health Care Platform (C-SHHCP) is a digital supportive care intervention designed for children with leukemia or brain tumors undergoing cancer treatment. The platform aims to strengthen communication and connection between children, their families, and health care providers and to provide holistic support addressing physical, psychological, social, and spiritual needs during cancer treatment.

Study summary

This multicenter randomized controlled trial aims to develop and evaluate two Smart Holistic Health Care Platforms (SHHCPs) for families of children with cancer in Taiwan: the Parent Smart Holistic Health Care Platform (P-SHHCP) for parents and the Child Smart Holistic Health Care Platform (C-SHHCP) for children. Children diagnosed with leukemia or brain tumors and their primary caregivers (parents) will be recruited from pediatric oncology and hematology units at four medical centers in northern Taiwan. The SHHCPs are designed to strengthen communication and connection between families and health care providers and to provide holistic support for physical, psychological, social, and spiritual needs during cancer treatment.The study will evaluate the effects of the P-SHHCP and C-SHHCP on the physical, psychological, social, and spiritual well-being of children with cancer and their parents during treatment.

Eligibility

Sex
ALL
Min age
7 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Parents: Parent of a child diagnosed with leukemia or a brain tumor. The child is between 2 and 18 years of age. The parent is the primary caregiver of the child, agrees to participate in the study, and is willing to complete self-administered questionnaires. Able to speak, understand, read, and write Chinese. Has access to the Internet. Has no cognitive impairment. Has not previously participated in another study involving a smart health care platform. Is not taking medications that may affect fatigue, anxiety, mood, or behavior. Children: Diagnosed with leukemia or a brain tumor. Between 7 and 18 years of age. Is not taking medications that may affect fatigue, anxiety, mood, or behavior. Able to communicate in Chinese. Has no cognitive impairment. Able to use a smartphone or tablet independently or with assistance from a caregiver. Will not participate in another smart health care platform study during the study period. Has a stable disease condition and emotional status. Exclusion Criteria: Parents: The child has not been diagnosed with leukemia or a brain tumor. The parent is not the primary caregiver of the child or is unwilling to participate in the study and complete the study questionnaires. Unable to speak, understand, read, or write Chinese. Does not have access to the Internet. Has cognitive impairment. Has previously participated in another study involving a smart health care platform. Is taking medications that may affect fatigue, anxiety, mood, or behavior. Children: Has a psychiatric disorder, such as schizophrenia, depression, or bipolar disorder, or has cognitive impairment or a sleep disorder. Has a congenital disease or congenital anomaly. Has a severe medical condition requiring treatment, such as a severe infection. Has terminal-stage cancer with multiple complications.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Taiwan University Children's Hospital Taipei Taiwan Recruiting

More National Defense Medical University, Taiwan trials in Taiwan

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07805096 on ClinicalTrials.gov ↗ ← All trials in Taiwan